Aluminium assay and evaluation of the local reaction at several time points after intramuscular administration of aluminium containing vaccines in the Cynomolgus monkey

Vaccine

Volumn 23, Issue 11, 2005, Pages 1359-1367

  Verdier, François ^a   Burnett, Roger ^b   Michelet Habchi, Claire ^c   Moretto, Philippe ^c   Fievet Groyne, Françoise ^a   Sauzeat, Elisabeth ^a  

^a SANOFI PASTEUR   (France)

^b MDS Pharma Services   (France)

^c CENTRE D ETUDES NUCLÉAIRES DE BORDEAUX GRADIGNAN   (France)

Author keywords

Aluminium; Animal study; Macrophagic myofasciitis

Indexed keywords

ALUMINUM HYDROXIDE; ALUMINUM PHOSPHATE; DIPHTHERIA TETANUS VACCINE; IMMUNOLOGICAL ADJUVANT; VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG TISSUE LEVEL; HISTOPATHOLOGY; IMMUNIZATION; INJECTION SITE; INJECTION SITE REACTION; MACROPHAGIC MYOFASCIITIS; MALE; MONKEY; MUSCLE DISEASE; NONHUMAN; PRIORITY JOURNAL; QUADRICEPS FEMORIS MUSCLE; TISSUE SECTION; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ALUMINUM COMPOUNDS; ALUMINUM HYDROXIDE; ANIMALS; DIPHTHERIA-TETANUS VACCINE; INJECTIONS, INTRAMUSCULAR; MACACA FASCICULARIS; MALE; MUSCLES; PHOSPHATES; TIME FACTORS;

EID: 12344251551     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.09.012     Document Type: Article

References (24)

1. A.T. Glenny, C.G. Pope, H. Waddington, and U. Wallace Immunological notes XXIII, the antigenic value of toxoid precipitated by potassium alum J Pathol Bacteriol 29 1926 31 40
2. R.K. Gupta Aluminum compounds as vaccine adjuvants Adv Drug Deliv Rev 32 3 1998 155 172
3. H. HogenEsch Mechanisms of stimulation of the immune response by aluminum adjuvants Vaccine 20 Suppl. 3 2002 S34 S39
4. M. Ulanova, A. Tarkowski, M. Hahn-Zoric, and L.A. Hanson The Common vaccine adjuvant aluminum hydroxide up-regulates accessory properties of human monocytes via an interleukin-4-dependent mechanism Infect Immun 69 2 2001 1151 1159
5. A.C. Rimaniol, G. Gras, F. Verdier, F. Capel, V.B. Grigoriev, and F. Porcheray Aluminum hydroxide adjuvant induces macrophage differentiation towards a specialized antigen-presenting cell type Vaccine 22 23/24 2004 3127 3135
6. A. Cosnes, M.L. Flechet, and J. Revuz Inflammatory nodular reactions after hepatitis B vaccination due to aluminium sensitization Contact Dermat 23 2 1990 65 67
7. J.R. Miliauskas, T. Mukherjee, and B. Dixon Postimmunization (vaccination) injection-site reactions. A report of four cases and review of the literature Am J Surg Pathol 17 5 1993 516 524
8. P.R. Pittman Aluminum-containing vaccine associated adverse events: role of route of administration and gender Vaccine 20 Suppl. 3 2002 S48 S50
9. D. Cominos, G. Strutton, and I. Busmanis Granulomas associated with Tetanus toxoid immunization Am J Dermatopathol 15 2 1993 114 117
10. E. Bergfors, B. Trollfors, and A. Inerot Unexpectedly high incidence of persistent itching nodules and delayed hypersensitivity to aluminum in children after the use of adsorbed vaccines from a single manufacturer Vaccine 22 1 2003 64 69
11. C.J. Clements, and E. Griffiths The global impact of vaccines containing aluminium adjuvants Vaccine 20 Suppl. 3 2002 S24 S33
12. IPCS. Environmental Health Criteria 194 - Aluminium. Geneva: World Health Org.; 1994.
13. R.K. Gherardi, M. Coquet, and P. Chérin Macrophagic myofasciitis: an emerging entity Lancet 1998 352
14. R.K. Gherardi, M. Coquet, P. Cherin, L. Belec, P. Moretto, and P.A. Dreyfus Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle Brain 124 Pt 9 2001 1821 1831
15. P. Cherin, P. Laforet, and R.K. Gherardi Macrophagic myofasciitis: description and etiopathogenic hypotheses, Study and Research Group on Acquired and Dysimmunity-related Muscular Diseases (GERMMAD) of the French Association against Myopathies (AFM) Rev Med Int 20 6 1999 483 489
16. Vaccine safety. Macrophagic myofasciitis and aluminium-containing vaccines. Wkly Epidemiol Rec 1999;74 (41):338-340.
17. A. Pineau, C. Durand, O. Guillard, B. Bureau, and J.F. Stalder Role of aluminium in skin reactions after Diphtheria-Tetanus-pertussis-poliomyelitis vaccination: an experimental study in rabbits Toxicology 73 1 1992 117 125
18. K. Redhead, G.J. Quinlan, R.G. Das, and J.M. Gutteridge Aluminium-adjuvanted vaccines transiently increase aluminium levels in murine brain tissue Pharmacol Toxicol 70 4 1992 278 280
19. 26Al Vaccine 15 12-13 1997 1314 1318
20. S.L. Hem Elimination of aluminum adjuvants Vaccine 20 Suppl. 3 2002 S40 S43
21. Llabador Y, Moretto P. Nuclear Microprobes in the life science. World Scientific, Singapore 1998:1-274.
22. P. Moretto, and L. Razafindrabe Nucl Instr Methods B104 1995 171
23. E. Nolte, E. Beck, C. Winklhofer, and C. Steinhausen Compartmental model for aluminium biokinetics Hum Exp Toxicol 20 2 2001 111 117
24. J.M. Heimlich, F.E. Regnier, J.L. White, and S.L. Hem The in vitro displacement of adsorbed model antigens from aluminium-containing adjuvants by interstitial proteins Vaccine 17 22 1999 2873 2881